Document:

Exhibit
4.4

 

WARRANT
AGREEMENT

 

This
Warrant Agreement (“Warrant Agreement”) is made as of [*], 2021, by and between HHG Capital Corporation, a
British Virgin Islands company (the “Company”), and American Stock Transfer & Trust Company, LLC (the “Warrant
Agent”).

 

WHEREAS,
the Company is engaged in a public offering (the “Public Offering”) of 5,000,000 units (the “Public
Units”) of the Company (and up to 750,000 additional Units if the underwriters’ over-allotment option is exercised
in full), each Unit consisting of one ordinary share, par value $0.0001 per share (the “Ordinary Shares”) and
one warrant (the “Public Warrant” or “Public Warrants”), each warrant entitling its holder
to purchase three quarters (3/4) of one Ordinary Share (the “Warrant Shares”);

 

WHEREAS,
the Company has received a binding commitment from HHG Capital Fund SP, its sponsor, to purchase up to an aggregate of
230,000 private units (which includes 13,500 private units to be purchased if the overallotment is exercised in full)
(collectively, the “Private Units” together with the Public Units, the “Units”), with
each Private Unit consisting of one Ordinary Share and one redeemable warrant pursuant to Subscription Agreement, dated [*],
2021 (the “Subscription Agreements”), and, in connection therewith, will issue and deliver an aggregate of
230,000 warrants underlying such units (the “Private Warrants”), each such Private Warrant entitling its
holder to purchase three quarters (3/4) of one Ordinary Share;

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form
S-1, No. 333-252885 (“Registration Statement”), for the registration, under the Securities Act of 1933, as
amended (the “Act”) of, among other securities, the Public Warrants;

 

 WHEREAS, in connection with any extension
of the period of time the Company has to consummate the Company’s initial business combination, the Company may issue up
to an additional 28,750 warrants, which will be identical to the Private Warrants, in consideration of certain loans as part of
units (“Extension Units”) that may be made by the sponsor or the Company’s officers, directors or affiliates
(“Extension Warrants”); 

   

WHEREAS,
the Company may issue up to an additional 50,000 warrants, which will be identical to the Private Warrants, in consideration of
certain working capital loans as part of units (“Working Capital Units”) that may be made by the sponsor or
the Company’s officers, directors or affiliates (“Working Capital Warrants,” together with the Public
Warrants, Private Warrants, Extension Warrants, and such other warrants as the Company issues from time to time hereunder,
the “Warrants”);

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection
with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants;

 

WHEREAS,
the Company desires to provide for the form, terms and provisions of the Warrants, including the terms upon which they shall be
issued and exercised, and the respective rights, limitation of rights and immunities of the Company, the Warrant Agent and the
holders of the Warrants; and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company
and countersigned by or on behalf of the Warrant Agent, as provided herein, the legally valid and binding obligations of the Company,
and to authorize the execution and delivery of this Warrant Agreement.

 

    	 

     

    

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.
Appointment of Warrant Agent. The Company
hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such
appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Warrant Agreement.

 

2.
Warrants.

 

2.1
Form of Warrant. Each Warrant shall be: (a) issued in registered form only, (b) in substantially the form of Exhibit A
hereto, the provisions of which are incorporated herein and (c) signed by, or bear the facsimile signature of, the Chairman of
the Board, the Chief Executive Officer or the Chief Financial Officer of the Company. In the event the person whose facsimile
signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant
before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of
issuance.

 

2.2
Uncertificated Warrants. Notwithstanding anything herein to the contrary, any Warrant, or portion thereof, may be issued
as part of, and be represented by, a Unit, Private Unit, Extension Unit, or Working Capital Unit, and any Warrant may be
issued in uncertificated or book-entry form through the Warrant Agent and/or the facilities of The Depository Trust Company (the
“Depository”) or other book-entry depositary system, in each case as determined by the Board of Directors of
the Company or by an authorized committee thereof. Any Warrant so issued shall have the same terms, force and effect as a certificated
Warrant that has been duly countersigned by the Warrant Agent in accordance with the terms of this Agreement.

 

2.3
Effect of Countersignature. Except with respect to uncertificated Warrants as described in Section 2.2 above, unless and
until countersigned by the Warrant Agent pursuant to this Warrant Agreement, a Warrant shall be invalid and of no effect and may
not be exercised by the holder thereof.

 

2.4
Registration.

 

2.4.1
Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”), for the registration
of the original issuance and transfers of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue
and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with
instructions delivered to the Warrant Agent by the Company.

 

2.4.2
Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent
may deem and treat the person in whose name such Warrant shall be registered upon the Warrant Register (“Registered Holder”)
as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other
writing on the Warrant certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise
thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

    	2

     

    

 

2.5
Detachability of Public Warrants. Each of the securities comprising the Public Units will begin to trade separately on
(i) the fifty-second (52nd) day after the date of the prospectus, or (ii) such earlier date as Kingswood Capital Markets,
division of Benchmark Investments, Inc., as representative of the underwriters (the “Representative”), shall
determine is acceptable (such date, the “Detachment Date”). In no event will separate trading of the securities
comprising the Public Units commence until the Company (i) files a Current Report on Form 8-K with the SEC including audited balance
sheet reflecting our receipt of the gross proceeds of this Public Offering and (ii) issues a press release announcing when such
separate trading will begin.

 

2.6
Private Warrants, Extension Warrants, and Working Capital Warrants. The Private Warrants, Extension Warrants,
and Working Capital Warrants will be issued in the same form as the Public Warrants except that so long as they are held by
the initial purchasers or any of their permitted transferees (as prescribed in the Subscription Agreement) as applicable, the
Private Warrants, Extension Warrants, and the Working Capital Warrants: (i) may be exercised for cash or on a cashless
basis, pursuant to subsection 3.3 hereof, and (ii) will not be redeemable by the Company. The Private Warrants may not be sold,
transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction
that would result in the effective economic disposition of, the Private Warrants (or any securities underlying the Private Warrants)
until 30 days following the completion of the Company’s initial business combination (except with respect to permitted transferees
as described in the Subscription Agreement). The provisions of this Section 2.6 may not be modified, amended or deleted without
the prior written consent of the Representative.

 

3.
Terms and Exercise of Warrants.

 

3.1
Warrant Price. Each Warrant shall, when countersigned by the Warrant Agent (except with respect to Uncertificated Warrants),
entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Warrant Agreement, to purchase from
the Company the number of Ordinary Shares stated therein, at $11.50 per full share, subject to the adjustments provided in Section
4 hereof. The term “Warrant Price” as used in this Warrant Agreement refers to the price per whole share at
which Ordinary Shares may be purchased at the time such Warrants are exercised. The Company will not issue fractional shares.
As a result, such Registered Holder must exercise Warrants in multiples of no less than two at the Warrant Price (subject to adjustment)
in order to validly exercise his, her or its Warrants.

 

3.2
Duration of Warrants. A Warrant may be exercised only during the period (“Exercise Period”) commencing
on the later to occur of (i) the completion of the Company’s initial business combination and (ii) 12 months following the
date of the Registration Statement is declared effective by the SEC, and terminating at 5:00 p.m., New York City time, on the
earlier to occur of (i) five years after the completion of the initial business combination, and (ii) the date fixed for redemption
of the Warrants as provided in Section 6 of this Warrant Agreement (“Expiration Date”). Except with respect
to the right to receive the Redemption Price (as set forth in Section 6 hereunder), each Warrant not exercised on or before the
Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Warrant Agreement shall
cease at the close of business on the Expiration Date. The Company may extend the duration of the Warrants by delaying the Expiration
Date; provided, however, that the Company will provide written notice of not less than 10 days to Registered Holders of such extension
and that such extension shall be identical in duration among all of the then outstanding Warrants.

 

    	3

     

    

 

3.3
Exercise of Warrants.

 

3.3.1
Cash Exercise. Subject to the provisions of the Warrant and this Warrant Agreement, a Warrant, when countersigned by the
Company, may be exercised by the Registered Holder thereof by surrendering it at the office of the Warrant Agent, or at the office
of its successor as Warrant Agent, currently being:

 

American
Stock Transfer & Trust Company, LLC

6201
15th Avenue

Brooklyn,
NY 11219

 

with
the subscription form, as set forth in the Warrant, duly executed, and by paying in full, in lawful money of the United States,
by certified or bank cashier’s check payable to the order of the Warrant Agent or by wire transfer to the Warrant Agent’s
JPMorgan bank account, the Warrant Price for each whole Warrant Share as to which the Warrant is exercised and any and all applicable
taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the Warrant Shares, and the issuance
of the Warrant Shares (such exercise, a “Cash Exercise”). A Cash Exercise in accordance with this Section 3.3.1
is available to the Registered Holder only during such times that there is an effective registration statement registering the
Warrant Shares, with the prospectus contained therein being available for the resale of the Warrant Shares.

 

3.3.2
Cashless Exercise. Notwithstanding anything contained herein to the contrary, if there is no effective registration statement
registering the Warrant Shares on any day the Registered Holder desires to exercise the Warrants and more than 60 days have passed
since the Company complete its initial business combination, the Registered Holder may exercise the Warrants in whole or in part
in lieu of making a cash payment, by providing notice to the Chief Executive Officer of the Company in a subscription form of
its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Shares determined
as follows:

 

X
= Y [(A-B)/A]

 

 where:

 

X
= the number of Warrant Shares to be issued to the Holder.

 

Y
= the number of Warrant Shares with respect to which this Warrant is being exercised.

 

A
= the fair market value of one Ordinary Share.

 

B
= the Warrant Price.

 

The
Registered Holder may not exercise any Warrants in the absence of a registration statement except pursuant to this Section
3.3.2. For purposes of this Section 3.3.2 and Section 4.1, the fair market value of one Ordinary Share is defined
as follows:

 

    	4

     

    

 

(i)
if the Company’s Ordinary Shares are listed and traded on the New York Stock Exchange, the NYSE American, the NASDAQ Global
Select Market, the NASDAQ Global Market or the NASDAQ Capital Market (each, a “Trading Market”), the fair market
value shall be deemed the average of the closing price on such Trading Market for the 20 trading days ending on the third trading
day immediately prior to the date the subscription form is submitted to the Company in connection with the exercise of the Warrant;
or

 

(ii)
if the Company’s Ordinary Shares are not listed on a Trading Market, but is traded in the over-the-counter market, the fair
market value shall be deemed to be the average of the bid price on such Trading Market for the 10 trading day ending on the third
trading day immediately prior to the date the subscription form is submitted in connection with the exercise of the Warrant; or

 

(iii)
if there is no active public market for the Company’s Ordinary Shares, the fair market value of the Ordinary Shares shall
be determined in good faith by the Company’s board of directors.

 

3.3.3
Fractional Shares. Notwithstanding any provision to the contrary contained in this Warrant Agreement, the Company shall
not be required to issue any fraction of a Warrant Share in connection with the exercise of Warrants, and in any case where the
Registered Holder would be entitled under the terms of the Warrants to receive a fraction of a Warrant Share upon the exercise
of such Registered Holder’s Warrants, issue or cause to be issued only the largest whole number of Warrant Shares issuable
on such exercise (and such fraction of a Warrant Share will be disregarded); provided, that if more than one Warrant certificate
is presented for exercise at the same time by the same Registered Holder, the number of whole Warrant Shares which shall be issuable
upon the exercise thereof shall be computed on the basis of the aggregate number of Warrant Shares issuable on exercise of all
such Warrants.

 

3.3.4
Issuance of Certificates. No later than three (3) business days following the exercise of any Warrant and the clearance
of the funds in payment of the Warrant Price pursuant to Section 3.3.1 or cashless exercise pursuant to Section 3.3.2, the Company
shall issue, or cause to be issued, to the Registered Holder of such Warrant a certificate or certificates representing (or at
the option of the Registered Holder, deliver electronically through the facilities of the Depository Trust Corporation) the number
of full Ordinary Shares to which he, she or it is entitled, registered in such name or names as may be directed by him, her or
it, and, if such Warrant shall not have been exercised or surrendered in full, a new countersigned Warrant for the number of shares
as to which such Warrant shall not have been exercised or surrendered. Notwithstanding the foregoing, the Company shall not deliver,
or cause to be delivered, any securities without applicable restrictive legend pursuant to the exercise of a Warrant unless (a)
a registration statement under the Act with respect to the Ordinary Shares issuable upon exercise of such Warrants is effective
and a current prospectus relating to the Ordinary Shares issuable upon exercise of the Warrants is available for delivery to the
Registered Holder of the Warrant or (b) in the opinion of counsel to the Company, the exercise of the Warrants is exempt from
the registration requirements of the Act and such securities are qualified for sale or exempt from qualification under applicable
securities laws of the states or other jurisdictions in which the Registered Holder resides. Warrants may not be exercised by,
or securities issued to, any Registered Holder in any state in which such exercise or issuance would be unlawful. In addition,
in no event will the Company be obligated to pay such Registered Holder any cash consideration upon exercise or otherwise “net
cash settle” the Warrant.

 

    	5

     

    

 

3.3.5
Valid Issuance. All Ordinary Shares issued upon the proper exercise or surrender of a Warrant in conformity with this Warrant
Agreement shall be validly issued, fully paid and non-assessable.

 

3.3.6
Date of Issuance. Each person or entity in whose name any such certificate for Ordinary Shares is issued shall, for all
purposes, be deemed to have become the holder of record of such shares on the date on which the Warrant was surrendered and payment
of the Warrant Price was made, irrespective of the date of delivery of such certificate, except that, if the date of such surrender
and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the
holder of such shares at the close of business on the next succeeding date on which the stock transfer books are open.

 

3.3.7
Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the
provisions contained in this subsection 3.3.7; however, no holder of a Warrant shall be subject to this subsection 3.3.7 unless
he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the
holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect
to such exercise, such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would
beneficially own in excess of 9.9% (the “Maximum Percentage”) of the Ordinary Shares outstanding immediately
after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of Ordinary Shares beneficially
owned by such person and its affiliates shall include the number of Ordinary Shares issuable upon exercise of the Warrant with
respect to which the determination of such sentence is being made, but shall exclude Ordinary Shares that would be issuable upon
(x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y)
exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by
such person and its affiliates (including, without limitation, any convertible notes or convertible preferred shares or warrants)
subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding
sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities
Exchange Act of 1934, as amended. For purposes of the Warrant, in determining the number of outstanding Ordinary Shares, the holder
may rely on the number of outstanding Ordinary Shares as reflected in (1) the Company’s most recent annual report on Form
10-K, quarterly report on Form 10-Q, current report on Form 8-K or other public filing with the SEC as the case may be, (2) a
more recent public announcement by the Company, or (3) any other notice by the Company or the Warrant Agent setting forth the
number of Ordinary Shares outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the
Company shall, within two (2) business days, confirm orally and in writing to such holder the number of Ordinary Shares then outstanding.
In any case, the number of outstanding Ordinary Shares shall be determined after giving effect to the conversion or exercise of
equity securities of the Company by the holder and its affiliates since the date as of which such number of outstanding Ordinary
Shares was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the
Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however, that any such
increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

 

    	6

     

    

 

4.
Adjustments.

 

4.1
Stock Dividends, Splits. If, after the date hereof, and subject to the provisions of Section 4.5 below, the number of outstanding
Ordinary Shares is increased by a stock dividend payable in Ordinary Shares, or by a forward or reverse split of Ordinary Shares,
or other similar event, then, on the effective date of such stock dividend, split or similar event, the number of Ordinary Shares
issuable on exercise of each Warrant shall be increased or decreased in proportion to such increase or decrease in outstanding
Ordinary Shares. A rights offering to all holders of the Ordinary Shares entitling holders to purchase Ordinary Shares at a price
less than the Fair Market Value shall be deemed a stock dividend of a number of Ordinary Shares equal to the product of (i) the
number of Ordinary Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights
offering that are convertible into or exercisable for the Ordinary Shares) multiplied by (ii) one (1) minus the quotient of (x)
the price per Ordinary Share paid in such rights offering divided by (y) the Fair Market Value. For purposes of this subsection
4.1, (i) if the rights offering is for securities convertible into or exercisable for Ordinary Shares, in determining the price
payable for the Ordinary Shares, there shall be taken into account any consideration received for such rights, as well as any
additional amount payable upon exercise or conversion and (ii) “Fair Market Value” shall mean the volume weighted
average price of the Ordinary Shares for the 20 trading days ending on the third trading day prior to the date on which the notice.

 

4.2
Aggregation of Shares. If, after the date hereof, and subject to the provisions of Section 4.6, the number of outstanding
Ordinary shares is decreased by a consolidation, combination or reclassification of Ordinary shares or other similar event, then,
on the effective date of such consolidation, combination, reclassification or similar event, the number of Ordinary shares issuable
on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding Ordinary shares.

 

4.3
Extraordinary Dividends. If the Company, at any time while the Warrants (or rights to purchase the Warrants) are outstanding
and unexpired, shall pay a dividend or make a distribution in cash, securities or other assets to the holders of the Ordinary
Shares on account of such Ordinary Shares (or other shares of the Company’s capital stock into which the Warrants are convertible),
other than (a) as described in subsection 4.1 above, (b) Ordinary Cash Dividends (as defined below), (c) to satisfy the conversion
rights of the holders of the Ordinary Shares in connection with a proposed initial business combination, (d) as a result of the
repurchase of Ordinary Shares by the Company in connection with an initial business combination or as otherwise permitted by the
Investment Management Trust Agreement between the Company and the Warrant Agent dated of even date herewith, or (e) in connection
with the Company’s liquidation and the distribution of its assets upon its failure to consummate a business combination
(any such non-excluded event being referred to herein as an “Extraordinary Dividend”), then the Warrant Price
shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and the
fair market value (as determined by the Company’s board of directors, in good faith) of any securities or other assets paid
on each Ordinary Share in respect of such Extraordinary Dividend. For purposes of this subsection 4.3, “Ordinary Cash Dividends”
means any cash dividend or cash distribution which, when combined on a per share basis with the per share amounts of all other
cash dividends and cash distributions paid on the Ordinary Shares during the 365-day period ending on the date of declaration
of such dividend or distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this
Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number
of Ordinary Shares issuable on exercise of each Warrant) does not exceed $0.50 (being 5% of the offering price of the Units in
the Offering).

 

    	7

     

    

 

4.4
Adjustments in Exercise Price.

 

4.4.1
Whenever the number of Ordinary Shares purchasable upon the exercise of the Warrants is adjusted, as provided in Sections 4.1
and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price, immediately prior
to such adjustment, by a fraction, (a) the numerator of which shall be the number of Ordinary Shares purchasable upon the exercise
of the Warrants immediately prior to such adjustment, and (b) the denominator of which shall be the number of Ordinary Shares
so purchasable immediately thereafter.

 

4.4.2
If (i) the Company issues additional Ordinary Shares or securities convertible into or exercisable or exchangeable for Ordinary
Shares for capital raising purposes in connection with the closing of the initial business combination at an issue price or effective
issue price of less than $9.35 per share, with such issue price or effective issue price to be determined in good faith by the
Board, (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest
thereon, available for funding the initial business combination, and (iii) the volume weighted average trading price of the Ordinary
Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial
business combination (the “Market Value”) is below $9.35 per share, the Warrant Price shall be adjusted (to
the nearest cent) to be equal to 115% of the Market Value, and the last sales price of the Ordinary Shares that triggers the Company’s
right to redeem the Warrants pursuant to Section 6.1 below shall be adjusted (to the nearest cent) to be equal to 165% of the
Market Value.

 

4.5
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding
Ordinary Shares (other than a change under Sections 4.1 or 4.2 hereof or one that solely affects the par value of such Ordinary
Shares), or, in the case of any merger or consolidation of the Company with or into another entity or conversion of the Company
as another entity (other than a consolidation or merger in which the Company is the continuing corporation and that does not result
in any reclassification or reorganization of the outstanding Ordinary Shares), or, in the case of any sale or conveyance to another
entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which
the Company is dissolved, the Registered Holders shall thereafter have the right to purchase and receive, upon the basis and upon
the terms and conditions specified in the Warrants and in lieu of the Ordinary Shares of the Company immediately theretofore purchasable
and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities
or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution
following any such sale or transfer, that the Registered Holder would have received if such Registered Holder had exercised his,
her or its Warrant(s) immediately prior to such event; and if any reclassification also results in a change in Ordinary Shares
covered by Sections 4.1 or 4.2, then such adjustment shall be made pursuant to Sections 4.1, 4.2, 4.3 and this Section 4.4. The
provisions of this Section 4.4 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations,
sales or other transfers.

 

    	8

     

    

 

4.6
Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise
of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting
from such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise
of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based.
Upon the occurrence of any event specified in Sections 4.1 through 4.5 the Company shall give written notice to each Registered
Holder, at the last address set forth for such Registered Holder in the Warrant Register, of the record date or the effective
date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

 

4.7
Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants
issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially
issued pursuant to this Warrant Agreement. However, the Company may, at any time, in its sole discretion, make any change in the
form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter
issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so
changed.

 

4.8
Notice of Certain Transactions. In the event that the Company shall (a) offer to holders of all its Ordinary Shares rights
to subscribe for or to purchase any securities convertible into Ordinary Shares or shares of stock of any class or any other securities,
rights or options, (b) issue any rights, options or warrants entitling all the holders of Ordinary Shares to subscribe for Ordinary
Shares, or (c) make a tender offer, redemption offer or exchange offer with respect to the Ordinary Shares, the Company shall
send to the Registered Holders a notice of such action or offer. Such notice shall be mailed to the Registered Holders at their
addresses as they appear in the Warrant Register, which shall specify the record date for the purposes of such dividend, distribution
or rights, or the date such issuance or event is to take place and the date of participation therein by the holders of Ordinary
Shares, if any such date is to be fixed, and shall briefly indicate the effect of such action on the Ordinary Shares and on the
number and kind of any other shares of stock and on other property, if any, and the number of Ordinary Shares and other property,
if any, issuable upon exercise of each Warrant and the Warrant Price after giving effect to any adjustment pursuant to this Section
4 which would be required as a result of such action. Such notice shall be given as promptly as practicable after the Company
has taken any such action.

 

4.9
Other Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections
of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i)
avoid an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case,
the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national
standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary
to effectuate the intent and purpose of this Section 4 and, if such firm determines that an adjustment is necessary, the terms
of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended
in such opinion

 

    	9

     

    

 

5.
Transfer and Exchange of Warrants.

 

5.1
Transfer of Public Warrants. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together
with the Unit in which such Public Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer
or exchange of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer
the Public Warrants included in such Unit. From and after the Detachment Date, this Section 5.1 will have no further force and
effect.

 

5.2
Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant
into the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed
and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate
number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent, in the case of certified warrants.
The Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon the Company’s request.

 

5.3
Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request
for exchange or transfer, and, thereupon, the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested
by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however,
that, in the event a Warrant surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant
and shall issue new Warrants in exchange therefor until the Warrant Agent has received an opinion of counsel for the Company stating
that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.

 

5.4
Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will
result in the issuance of a warrant certificate for a fraction of a warrant.

 

5.5
Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.6
Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance
with the terms of this Warrant Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and
the Company, whenever required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the
Company for such purpose.

 

5.7
Private Warrants, Extension Warrants, and Working Capital Warrants. The Warrant Agent shall not register any transfer
of Private Warrants, Extension Warrants, or Working Capital Warrants until after the consummation by the Company of an
initial business combination, except for transfers made in accordance with Section 2.5 hereof, on the condition that prior to
such registration for transfer, the Warrant Agent shall be presented with written documentation pursuant to which each transferee
or the trustee or legal guardian for such transferee agrees to be bound by the terms of the Subscription Agreements and any other
applicable agreement the transferor is bound by.

 

    	10

     

    

 

6.
Redemption.

 

6.1
Redemption. Subject to the second sentence of this Section 6.1, all (and not less than all) of the outstanding Warrants
may be redeemed, in whole and not in part, at the option of the Company, at any time from and after the Warrants become exerciseble,
and prior to their expiration, at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at the price of
$0.01 per Warrant (“Redemption Price”); provided that the last sales price of the Ordinary Shares has been
equal to or greater than $16.50 per share (subject to adjustment for splits, dividends, recapitalizations and other similar events),
for any twenty (20) trading days within a thirty (30) trading day period ending on the third business day prior to the date on
which notice of redemption is given and provided further that (i) there is a current registration statement in effect with respect
to the Ordinary Shares underlying the Warrants for each day in the 30-Day Trading Period and continuing each day thereafter until
the Redemption Date (defined below) or (ii) the cashless exercise of the Warrants pursuant to Section 3.3.2 is exempt from
the registration requirements under the Act. For avoidance of doubt, if and when the warrants become redeemable by the Company
under this Section, the Company may exercise its redemption right, even if it is unable to register or qualify the Warrant Shares
for sale under all applicable state securities laws.

 

6.2
Date Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants that are
subject to redemption, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption
shall be mailed by first class mail, postage prepaid, by the Company not less than 30 days prior to the date fixed for redemption
to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on the Warrant Register.
Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given, whether or not the Registered
Holder received such notice.

 

6.3
Exercise After Notice of Redemption. The Warrants may be exercised in accordance with Section 3 of this Warrant Agreement
at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior to the Redemption
Date; provided that the Company may require the Registered Holder who desires to exercise the Warrant to elect cashless exercise
as set forth under Section 3.3.2, and such Registered Holder must exercise the Warrants on a cashless basis if the Company so
requires. On and after the Redemption Date, the Registered Holder of the Warrants shall have no further rights except to receive,
upon surrender of the Warrants, the Redemption Price.

 

6.4
No Other Rights to Cash Payment. Except for a redemption in accordance with this Section 6, no Registered Holder of any
Warrant shall be entitled to any cash payment whatsoever from the Company in connection with the ownership, exercise or surrender
of any Warrant under this Warrant Agreement.

 

6.5
Exclusion of Certain Warrants. The Company agrees that the redemption rights provided for by this Section 6 apply only
to outstanding Warrants. To the extent a person holds rights to purchase Warrants, such purchase rights shall not be extinguished
by redemption. However, once such purchase rights are exercised, the Company may redeem the Warrants issued upon such exercise
provided that the criteria for redemption is met. Additionally, any of the Private Warrants, Extension Warrants, or Working
Capital Warrants shall not be redeemable by the Company as long as such Private Warrants, Extension Warrants, or Working
Capital Warrants continue to be held by initial purchasers and affiliates or their permitted transferees (as prescribed in Section
5.7 hereof). However, once such Private Warrants, Extension Warrants, or Working Capital Warrants are no longer held by
the initial purchasers or their affiliates or permitted transferees, such Private Warrants, Extension Warrants, or Working
Capital Warrants shall then be redeemable by the Company pursuant to Section 6 hereof. The provisions of this Section 6.5 may
not be modified, amended or deleted without the prior written consent of the Representative.

 

    	11

     

    

 

7.
Other Provisions Relating to Rights of Registered
Holders of Warrants.

 

7.1
No Rights as Shareholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a shareholder
of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive
rights to vote or to consent or to receive notice as shareholders in respect of the meetings of shareholders or the election of
directors of the Company or any other matter.

 

7.2
Lost, Stolen Mutilated or Destroyed Warrants. If any Warrant is lost, stolen, mutilated or destroyed, the Company and the
Warrant Agent may, on such terms as to indemnity or otherwise as they may in their discretion impose (which terms shall, in the
case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor and date as the Warrant
so lost, stolen, mutilated or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company,
whether or not the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3
Reservation of Ordinary Shares. The Company shall at all times reserve and keep available a number of its authorized but
unissued Ordinary Shares that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to
this Warrant Agreement.

 

7.4
Registration of Ordinary Shares. The Company agrees that as soon as practicable, but in no event later than thirty (30)
business days after the closing of the initial business combination, it shall use its best efforts to file with the SEC a registration
statement for the registration under the Act of the Ordinary Shares issuable upon exercise of the Warrants, and to cause the same
to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto,
until the expiration of the Warrants in accordance with the provisions of this Agreement. In addition, the Company agrees to use
its best efforts to register the Ordinary Shares issuable upon exercise of the Warrants under state blue sky laws, to the extent
an exemption is not available.

 

8.
Concerning the Warrant Agent and Other Matters.

 

8.1
Payment of Taxes. The Company will, from time to time, promptly pay all taxes and charges that may be imposed upon the
Company or the Warrant Agent in respect of the issuance or delivery of Ordinary Shares upon the exercise of Warrants, but the
Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

 

    	12

     

    

 

8.2
Resignation, Consolidation, or Merger of Warrant Agent.

 

8.2.1
Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties
and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the
Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall
appoint, in writing, a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment
within a period of 30 days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by
the Registered Holder of the Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the Company),
then the Registered Holder of any Warrant may apply to the Supreme Court of the State of New York for the County of New York for
the appointment of a successor Warrant Agent. Any successor Warrant Agent, whether appointed by the Company or by such court,
shall be a corporation organized and existing under the laws of the State of New York, in good standing and having its principal
office in the Borough of Manhattan, City and State of New York, and be authorized under such laws to exercise corporate trust
powers and subject to supervision or examination by federal or state authorities. After appointment, any successor Warrant Agent
shall be vested with all the authority, powers, rights, immunities, duties and obligations of its predecessor Warrant Agent with
like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but, if for any reason it becomes
necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder;
and, upon request of any successor Warrant Agent, the Company shall make, execute, acknowledge, and deliver any and all instruments
in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers,
rights, immunities, duties and obligations.

 

8.2.2
Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice
thereof to the predecessor Warrant Agent and the transfer agent for the Ordinary Shares not later than the effective date of any
such appointment.

 

8.2.3
Merger or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may
be consolidated or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall
be the successor Warrant Agent under this Warrant Agreement without any further act on the part of the Company or the Warrant
Agent.

 

8.3
Fees and Expenses of Warrant Agent.

 

8.3.1
Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as Warrant Agent hereunder
and will reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution
of its duties hereunder.

 

8.3.2
Further Assurances. The Company agrees to perform, execute, acknowledge and deliver, or cause to be performed, executed,
acknowledged and delivered, all such further and other acts, instruments and assurances as may reasonably be required by the Warrant
Agent for the carrying out or performing of the provisions of this Warrant Agreement.

 

    	13

     

    

 

8.4
Liability of Warrant Agent.

 

8.4.1
Reliance on Company Statement. Whenever, in the performance of its duties under this Warrant Agreement, the Warrant Agent
shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering
any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be
deemed to be conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer
or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for
any action taken or suffered in good faith by it pursuant to the provisions of this Warrant Agreement.

 

8.4.2
Indemnity. The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith.
The Company agrees to indemnify the Warrant Agent and hold it harmless against any and all liabilities, including judgments, costs
and reasonable counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Warrant Agreement, except
as a result of the Warrant Agent’s gross negligence, willful misconduct or bad faith.

 

8.4.3
Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Warrant Agreement or with
respect to the validity or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any
breach by the Company of any covenant or condition contained in this Warrant Agreement or in any Warrant; nor shall it be responsible
to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method or amount of any
such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it, by any act
hereunder, be deemed to make any representation or warranty as to the authorization or reservation of any Ordinary Shares to be
issued pursuant to this Warrant Agreement or any Warrant or as to whether any Ordinary Shares will when issued be valid and fully
paid and non-assessable.

 

8.5
Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Warrant Agreement and agrees to perform
the same upon the terms and conditions herein set forth and, among other things, shall account promptly to the Company with respect
to Warrants exercised and concurrently account for, and pay to the Company, all moneys received by the Warrant Agent for the purchase
of shares of the Company’s Ordinary Shares through the exercise of Warrants.

 

8.6
Waiver. The Warrant Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (“Claim”)
in or to any distribution of the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of
the date hereof, by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse,
reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever.

 

    	14

     

    

 

9.
Miscellaneous Provisions.

 

9.1
Successors. All the covenants and provisions of this Warrant Agreement by or for the benefit of the Company or the Warrant
Agent shall bind and inure to the benefit of their respective successors and assigns.

 

9.2
Notices. Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the Warrant Agent
or by the Registered Holder of any Warrant to or on the Company shall be delivered by hand or sent by registered or certified
mail or overnight courier service, addressed (until another address is filed in writing by the Company with the Warrant Agent)
as follows:

 

HHG
Capital Corporation

0/F,
Montery Plaza

15
Chong Yip Street, Hong Kong

Attn:
Kin (Stephen) Sze

 

with
a copy (which shall not constiute notice) to:

 

Loeb
& Loeb LLP

345
Park Avenue

New
York, New York 10154

Attn:
Lawrence Venick

 

Any
notice, statement or demand authorized by this Warrant Agreement to be given or made by the Registered Holder of any Warrant or
by the Company to or on the Warrant Agent shall be delivered by hand or sent by registered or certified mail or overnight courier
service, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

 

American
Stock Transfer & Trust Company, LLC

6201
15th Avenue

Brooklyn,
NY 11219

Attn:
Reorg Deparment

 

Any
notice, sent pursuant to this Warrant Agreement shall be effective, if delivered by hand, upon receipt thereof by the party to
whom it is addressed, if sent by overnight courier, on the next business day of the delivery to the courier, and if sent by registered
or certified mail on the third day after registration or certification thereof.

 

9.3
Applicable Law. The validity, interpretation, and performance of this Warrant Agreement and of the Warrants shall be governed
in all respects by the laws of the State of New York, without giving effect to conflict of laws. The Company and the Warrant Agent
hereby agree that any action, proceeding or claim against either of them arising out of or relating in any way to this Warrant
Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern
District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company and the
Warrant Agent hereby waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.
Any such process or summons to be served upon the Company or the Warrant Agent may be served by transmitting a copy thereof by
registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.2
hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the party receiving such service in
any action, proceeding or claim.

 

    	15

     

    

 

9.4
Persons Having Rights under this Warrant Agreement. Nothing in this Warrant Agreement expressed and nothing that may be
implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation
other than the parties hereto and the Registered Holders of the Warrants and, for the purposes of Sections 7.4, 9.4 and 9.8 hereof,
the Representative and the underwriters, any right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant,
condition, stipulation, promise, or agreement hereof. Kingswood Capital Markets, division of Benchmark Investments, Inc. shall
be deemed to be a third party beneficiary of this Agreement with respect to Sections 7.4, 9.4 and 9.8 hereof. All covenants, conditions,
stipulations, promises, and agreements contained in this Warrant Agreement shall be for the sole and exclusive benefit of the
parties hereto (and Kingswood Capital Markets with respect to Section 7.4, 9.4 and 9.8 hereof) and their successors and assigns
and of the Registered Holders of the Warrants.

 

9.5
Examination of the Warrant Agreement. A copy of this Warrant Agreement shall be available at all reasonable times at the
office of the Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of
any Warrant. The Warrant Agent may require any such Registered Holder to submit his, her or its Warrant for inspection.

 

9.6
Counterparts; Facsimile Signatures. This Warrant Agreement may be executed in any number of counterparts, and each of such
counterparts shall, for all purposes, be deemed to be an original, and all such counterparts shall together constitute one and
the same instrument. Facsimile signatures shall constitute original signatures for all purposes of this Warrant Agreement.

 

9.7
Effect of Headings. The section headings herein are for convenience only and are not part of this Warrant Agreement and
shall not affect the interpretation thereof

 

9.8
Amendments. This Warrant Agreement and any Warrant certificate may be amended by the parties hereto by executing a supplemental
warrant agreement (a “Supplemental Agreement”), without the consent of any of the Warrant Holders, for the
purpose of (i) curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein, or making
any other provisions with respect to matters or questions arising under this Warrant Agreement that is not inconsistent with the
provisions of this Warrant Agreement or the Warrant certificates, (ii) evidencing the succession of another corporation to the
Company and the assumption by any such successor of the covenants of the Company contained in this Warrant Agreement and the Warrants,
(iii) evidencing and providing for the acceptance of appointment by a successor Warrant Agent with respect to the Warrants, (iv)
adding to the covenants of the Company for the benefit of the Registered Holders or surrendering any right or power conferred
upon the Company under this Warrant Agreement, or (viii) amending this Warrant Agreement and the Warrants in any manner that the
Company may deem to be necessary or desirable and that will not adversely affect the interests of the Registered Holders in any
material respect. All other modifications or amendments to this Warrant Agreement, including any amendment to increase the Warrant
Price or shorten the Exercise Period, shall require the written consent or vote of the Registered Holders of a majority of the
then outstanding Warrants. Notwithstanding the foregoing, the Company may extend the duration of the Exercise Period in accordance
with Section 3.2 without such consent.

 

9.9
Severability. This Warrant Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision
hereof shall not affect the validity or enforceability of this Warrant Agreement or of any other term or provision hereof. Furthermore,
in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part
of this Warrant Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be
valid and enforceable.

 

[SIGNATURE
PAGE FOLLOWS]

 

    	16

     

    

 

IN
WITNESS WHEREOF, this Warrant Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	HHG
    CAPITAL CORPORATION
	 	 
	 	By:	 
	 	Name:	Kin
    (Stephen) Sze 
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	AMERICAN
    STOCK TRANSFER & TRUST COMPANY, LLC
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

Signature
Page To The Warrant AgreementExhibit
10.1

 

____,
2021

 

HHG
Capital Corporation

40/F,
Montery Plaza

15
Chong Yip Street, Hong Kong

 

Kingswood
Capital Markets,

division
of Benchmark Investments, Inc.

17
Battery Pl Suite 625

New
York, NY 10004

 

Brookline
Capital Markets,

a
division of Arcadia Securities, LLC

600
Lexington Avenue, 33rd Floor

New
York, NY 10022

 

	 	Re:	Initial
    Public Offering

 

Ladies
and Gentlemen:

 

This
letter is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”)
entered into by and between HHG Capital Corporation, a British Virgin Islands company (the “Company”),
and Kingswood Capital Markets, division of Benchmark Investments, Inc., as Representative (the “Representative”)
of the several underwriters named on Schedule A thereto (the “Underwriters”), relating to an underwritten
initial public offering (the “IPO”) of the Company’s units (the “Units”),
each comprised of one ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”)
and one redeemable warrant, each warrant entitling its holder to purchase 3/4 of one Ordinary Share at an exercise price of $11.50
per full share (the “Warrants”). Certain capitalized terms used herein are defined in paragraph 14 hereof.

 

In
order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the IPO, and in
recognition of the benefit that such IPO will confer upon the undersigned as a shareholder of the Company, and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned hereby agrees with the
Company as follows:

 

1.
If the Company solicits approval of its shareholders of a Business Combination, the undersigned will vote all Ordinary Shares
beneficially owned by him, her or it, whether acquired before, in or after the IPO, in favor of such Business Combination.

 

2.
(a) Unless the Company’s stockholders are previously given the option to redeem their shares in connection with amending
applicable documents to extend the time that the Company has to complete a Business Combination and that the Company fails to
consummate a Business Combination within 12 (or up to 18) months from the closing of the Company’s IPO from the closing
of the Company’s IPO, the undersigned shall take all reasonable steps to (i) cause the Trust Fund to be liquidated and distributed
to the holders of the IPO Shares and (ii) cause the Company to liquidate as soon as reasonably practicable.

 

    	 

    	 

    

 

(b)
The undersigned hereby waives any and all right, title, interest or claim of any kind in or to any distribution of the Trust Fund
and any remaining net assets of the Company as a result of such liquidation with respect to his, her or its Insider Shares [including
any shares underlying the Private Units]1 (“Claim”) and hereby waives any Claim the undersigned
may have in the future as a result of, or arising out of, any contracts or agreements with the Company and will not seek recourse
against the Trust Fund for any reason whatsoever. [The undersigned acknowledges and agrees that there will be no distribution
from the Trust Fund with respect to any Warrants or Rights underlying the Private Units, all of which will terminate on the Company’s
liquidation.]2

 

[(c)
In the event of the liquidation of the Trust Fund, the undersigned agrees to indemnify and hold harmless the Company against any
and all loss, liability, claims, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses
reasonably incurred in investigating, preparing or defending against any litigation, whether pending or threatened, or any claim
whatsoever) which the Company may become subject as a result of any claim by any vendor or other person who is owed money by the
Company for services rendered or products sold or contracted for, but only to the extent necessary to ensure that such loss, liability,
claim, damage or expense does not reduce the amount of funds in the Trust Fund; provided, that such indemnity shall not apply
if such vendor or other person has executed an agreement waiving any claims against the Trust Fund.]3

 

3.
[In the event that the Company does not consummate a Business Combination and must liquidate and its remaining net assets are
insufficient to complete such liquidation, the undersigned agrees to advance such funds necessary to complete such liquidation
and agrees not to seek recourse for such expenses.]4

 

4.
The undersigned will escrow all of his, her or its Insider Shares pursuant to the terms of a Stock Escrow Agreement, which the
Company will enter into with the undersigned and an escrow agent acceptable to the Company.

 

5.
[The undersigned agrees that until the Company consummates a Business Combination, the undersigned’s Private Units will
be subject to the transfer restrictions described in the Subscription Agreement relating to the undersigned’s Private Units.]5

 

6.
In order to minimize potential conflicts of interest which may arise from multiple affiliations, the undersigned agrees to present
to the Company for its consideration, prior to presentation to any other person or entity, any suitable opportunity to acquire
a target business, until the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company,
subject to any pre-existing fiduciary and contractual obligations the undersigned might have.

 

 

1NTD:
Only include for HHG Capital Fund SP.

2NTD:
Only include for HHG Capital Fund SP.

3NTD:
Only include for HHG Capital Fund SP.

4NTD:
Only include for HHG Capital Fund SP.

5NTD:
Only include for HHG Capital Fund SP.

 

    	2

     

    

 

7.
The undersigned acknowledges and agrees that prior to entering into a Business Combination with a target business that is affiliated
with any Insiders of the Company or their affiliates, including any company that is a portfolio company of, or otherwise affiliated
with, or has received financial investment from, an entity with which any Insider or their affiliates is affiliated, such transaction
must be approved by a majority of the Company’s disinterested independent directors and the Company must obtain an opinion
from an independent investment banking firm that such Business Combination is fair to the Company’s unaffiliated shareholders
from a financial point of view.

 

8.
Neither the undersigned, any member of the family of the undersigned, nor any affiliate of the undersigned will be entitled to
receive and will not accept any compensation or other cash payment prior to, or for services rendered in connection with, the
consummation of the Business Combination; provided that the Company shall be allowed to repay in cash upon consummation
of the Business Combination (i) working capital loans made by the undersigned to the Company and (ii) loans made by the
undersigned to the Company in connection with the extension of the period of time in which the Company has to consummate a Business
Combination. Notwithstanding the foregoing, the undersigned and any affiliate of the undersigned shall be entitled to reimbursement
from the Company for their out-of-pocket expenses incurred in connection with identifying, investigating and consummating a Business
Combination.

 

9.
Neither the undersigned, any member of the family of the undersigned, nor any affiliate of the undersigned will be entitled to
receive or accept a finder’s fee or any other compensation in the event the undersigned, any member of the family of the
undersigned or any affiliate of the undersigned originates a Business Combination.

 

10.
[The undersigned agrees to be a director/officer of the Company until the earlier of the consummation by the Company of a Business
Combination or the liquidation of the Company. The undersigned’s biographical information previously furnished to the Company
and the Representative is true and accurate in all material respects, does not omit any material information with respect to the
undersigned’s biography and contains all of the information required to be disclosed pursuant to Item 401 of Regulation
S-K, promulgated under the Securities Act of 1933.]6 The undersigned’s FINRA Questionnaire previously furnished
to the Company and the Representative is true and accurate in all material respects. The undersigned represents and warrants that:

 

	 	(a)	He,
    she or it has never had a petition under the federal bankruptcy laws or any state insolvency law been filed by or against
    (i) him, her or it, or any partnership in which he or she was a general partner at or within two years before the time of
    filing; or (ii) any corporation or business association of which he or she was an executive officer at or within two years
    before the time of such filing;

 

 

6NTD:
Only remove for HHG Capital Fund SP and Forever Happiness Limited.

 

    	3

     

    

 

	 	(b)	He,
    she or it has never had a receiver, fiscal agent or similar officer been appointed by a court for his business or property,
    or any such partnership;
	 	 	 
	 	(c)	He,
    she or it has never been convicted of fraud in a civil or criminal proceeding;
	 	 	 
	 	(d)	He,
    she or it has never been convicted in a criminal proceeding or named the subject of a pending criminal proceeding (excluding
    traffic violations and minor offenses);
	 	 	 
	 	(e)	He,
    she or it has never been the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of
    any court of competent jurisdiction, permanently or temporarily enjoining or otherwise limiting him, her or it from (i) acting
    as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage
    transaction merchant, any other person regulated by the Commodity Futures Trading Commission (“CFTC”) or an associated
    person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated
    person, director or employee of any investment company, bank, savings and loan association or insurance company, or from engaging
    in or continuing any conduct or practice in connection with any such activity; or (ii) engaging in any type of business practice;
    or (iii) engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with
    any violation of federal or state securities or federal commodities laws;
	 	 	 
	 	(f)	He,
    she, or it has never been the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of
    any federal or state authority barring, suspending or otherwise limiting for more than 60 days his, her or its right to engage
    in any activity described in 10(e)(i) above, or to be associated with persons engaged in any such activity;
	 	 	 
	 	(g)	He,
    she, or it has never been found by a court of competent jurisdiction in a civil action or by the SEC to have violated any
    federal or state securities law, where the judgment in such civil action or finding by the SEC has not been subsequently reversed,
    suspended or vacated;
	 	 	 
	 	(h)	He,
    she, or it has never been found by a court of competent jurisdiction in a civil action or by the CFTC to have violated any
    federal commodities law, where the judgment in such civil action or finding by the CFTC has not been subsequently reversed,
    suspended or vacated;
	 	 	 
	 	(i)	He,
    she, or it has never been the subject of, or a party to, any Federal, State or foreign judicial or administrative order, judgment,
    decree or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of (i) any Federal, State
    or foreign securities or commodities law or regulation, (ii) any law or regulation respecting financial institutions or insurance
    companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil
    money penalty or temporary or permanent cease-and desist order, or removal or prohibition order or (iii) any law or regulation
    prohibiting mail or wire fraud or fraud in connection with any business entity;

 

    	4

     

    

 

	 	(j)	He,
    she or it has never been the subject of, or party to, any sanction or order, not subsequently reversed, suspended or vacated,
    or any self-regulatory organization, any registered entity, or any equivalent exchange, association, entity or organization
    that has disciplinary authority over its members or persons associated with a member;
	 	 	 
	 	(k)	He,
    she or it has never been convicted of any felony or misdemeanor: (i) in connection with the purchase or sale of any security;
    (ii) involving the making of any false filing with the SEC; or (iii) arising out of the conduct of the business of an underwriter,
    broker, dealer, municipal securities dealer, investment advisor or paid solicitor of purchasers of securities;
	 	 	 
	 	(l)	He,
    she or it was never subject to a final order of a state or foreign securities commission (or an agency of officer of a state
    performing like functions); a state or foreign authority that supervises or examines banks, savings associations, or credit
    unions; a state or foreign insurance commission (or an agency or officer of a state performing like functions); an appropriate
    federal or foreign banking agency; the CFTC; or the National Credit Union Administration that is based on a violation of any
    law or regulation that prohibits fraudulent, manipulative, or deceptive conduct;
	 	 	 
	 	(m)	He,
    she or it has never been subject to any order, judgment or decree of any court of competent jurisdiction, that, at the time
    of the sale of the Units, restrained or enjoined him, her or it from engaging or continuing to engage in any conduct or practice:
    (i) in connection with the purchase or sale of any security; (ii) involving the making of any false filing with the SEC or
    any foreign regulatory agency with similar functions; or (iii) arising out of the conduct of the business of an underwriter,
    broker, dealer, municipal securities dealer, investment adviser or paid solicitor of purchasers of securities;
	 	 	 
	 	(n)	He,
    she or it has never been subject to any order of the SEC or any foreign regulatory agency with similar functions that orders
    him, her or it to cease and desist from committing or causing a future violation of: (i) any scienter-based anti-fraud provision
    of the federal securities laws, including, but not limited to, Section 17(a)(1) of the Securities Act, Section 10(b) of the
    Exchange Act and Rule 10b-5 thereunder, Section 15(c) and Section 206(1) of the Advisers Act or any other rule or regulation
    thereunder; or (ii) Section 5 of the Securities Act;

 

    	5

     

    

 

	 	(o)	He,
    she or it has never filed (as a registrant or issuer), or been named as an underwriter in any registration statement or Regulation
    A offering statement filed with the SEC that was the subject of a refusal order, stop order, or order suspending the Regulation
    A exemption, or is, currently, the subject of an investigation or proceeding to determine whether a stop order or suspension
    order should be issued;
	 	 	 
	 	(p)	He,
    she or it has never been subject to a United States Postal Service false representation order, or is currently subject to
    a temporary restraining order or preliminary injunction with respect to conduct alleged by the United States Postal Service
    to constitute a scheme or device for obtaining money or property through the mail by means of false representations;
	 	 	 
	 	(q)	He,
    she or it is not subject to a final order of a state securities commission (or an agency of officer of a state performing
    like functions); a state authority that supervises or examines banks, savings associations, or credit unions; a state insurance
    commission (or an agency or officer of a state performing like functions); an appropriate federal banking agency; the CFTC;
    or the National Credit Union Administration that bars the undersigned from: (i) association with an entity regulated by such
    commission, authority, agency or officer; (ii) engaging in the business of securities, insurance or banking; or (iii) engaging
    in savings association or credit union activities;
	 	 	 
	 	(r)	He,
    she or it is not subject to an order of the SEC entered pursuant to section 15(b) or 15B(c) of the Securities Exchange Act
    of 1934 (the “Exchange Act”) or section 203(e) or 203(f) of the Investment Advisers Act of 1940 (the “Advisers
    Act”) that: (i) suspends or revokes the undersigned’s registration as a broker, dealer, municipal securities dealer
    or investment adviser; (ii) places limitations on the activities, functions or operations of, or imposes civil money penalties
    on, such person; or (iii) bars the undersigned from being associated with any entity or from participating in the offering
    of any penny stock; and
	 	 	 
	 	(s)	He,
    she or it has never been suspended or expelled from membership in, or suspended or barred from association with a member of,
    a securities self-regulatory organization (e.g., a registered national securities exchange or a registered national or affiliated
    securities association) for any act or omission to act constituting conduct inconsistent with just and equitable principles
    of trade.

 

11.
The undersigned has full right and power, without violating any agreement by which he, she or it is bound, to enter into this
letter agreement [and to serve as a Director and/or officer of the Company]7. 

 

 

7NTD: Only
remove for HHG Capital Fund SP and Forever Happiness Limited.

 

    	6

     

    

 

12.
The undersigned hereby waives his, her or its right to exercise redemption rights with respect to any Ordinary Shares owned or
to be owned by the undersigned, directly or indirectly (or to sell such shares to the Company in a tender offer), whether purchased
by the undersigned prior to the IPO, in the IPO or in the aftermarket, and agrees that he, she or it will not seek redemption
with respect to or otherwise sell, such shares in connection with any vote to approve a Business Combination with respect thereto,
a vote to amend the provisions of the Company’s Amended and Restated Memorandum and Articles of Association, or a tender
offer by the Company prior to a Business Combination.

 

13.
The undersigned hereby agrees to not propose, or vote in favor of, an amendment to the Company’s Amended and Restated Memorandum
and Articles of Association with respect to the Company’s pre-Business Combination activities prior to the consummation
of a Business Combination unless the Company offers holders of IPO Shares the right to receive their pro rata portion of the funds
then held in the Trust Fund.

 

14.
In connection with Section 5-1401 of the General Obligations Law of the State of New York, this letter agreement shall be governed
by, and construed in accordance with, the laws of the State of New York without regard to principles of conflicts of law that
would result in the application of the substantive law of another jurisdiction. The parties hereto agree that any action, proceeding
or claim arising out of or relating in any way to this letter agreement shall be resolved through final and binding arbitration
in accordance with the International Arbitration Rules of the American Arbitration Association (“AAA”). The arbitration
shall be brought before the AAA International Center for Dispute Resolution’s offices in New York City, New York, will be
conducted in English and will be decided by a panel of three arbitrators selected from the AAA Commercial Disputes Panel and that
the arbitrator panel’s decision shall be final and enforceable by any court having jurisdiction over the party from whom
enforcement is sought. The cost of such arbitrators and arbitration services, together with the prevailing party’s legal
fees and expenses, shall be borne by the non-prevailing party or as otherwise directed by the arbitrators.

 

15.
As used herein, (i) a “Business Combination” shall mean a merger, share exchange, asset acquisition,
contractual arrangement, share purchase, recapitalization, reorganization or other similar business combination with one or more
businesses or entities; (ii) “Insiders” shall mean all officers, directors and shareholders of the Company
immediately prior to the IPO; (iii) “Insider Shares” shall mean all of the Ordinary Shares of the Company
acquired by an Insider prior to the IPO and any Ordinary Shares underlying the Private Units; (iv) “IPO Shares”
shall mean the Ordinary Shares issued in the Company’s IPO; (v) [“Private Units” shall mean (x)
the Units purchased in the private placement taking place simultaneously with the consummation of the Company’s IPO and
(y) the additional Units that may be purchased in connection with the exercise of the over-allotment option by the underwriters
in the IPO as described in the Registration Statement;]8 (vi) “Registration Statement” means
the registration statement on Form S-1 filed by the Company with respect to the IPO; and (vii) “Trust Fund”
shall mean the trust fund into which a portion of the net proceeds of the Company’s IPO will be deposited.

 

 

8NTD: Only
include for HHG Capital Fund SP.

 

    	7

     

    

 

16.
Any notice, consent or request to be given in connection with any of the terms or provisions of this letter agreement shall be
in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested),
by hand delivery, by electronic mail or by facsimile transmission.

 

If
to the Representative:

 

Kingswood
Capital Market,

division
of Benchmark Investments, Inc.

17
Battery Place, Suite 625

New
York, NY 10004

Attn:
Joseph T. Rallo

Email:
jrallo@kingswoodcm.com

 

with
a copy (which copy shall not constitute notice) to:

 

Nelson
Mullins Riley & Scarborough LLP

101
Constitution Avenue,

Washington
D.C., 20001

Attn:
Andy Tucker, Esq.

Email:
andy.tucker@nelsonmullins.com

 

If
to the Company:

 

HHG
Capital Corporation

 

40/F,
Montery Plaza

15
Chong Yip Street, Hong Kong

Attn:
Kin (Stephen) Sze, Chief Executive Officer

Email:
stephen.sze@silverbricks.com.hk

 

with
a copy (which copy shall not constitute notice) to:

 

Loeb
& Loeb LLP

345
Park Avenue

New
York, NY 10154

Attn:
Lawrence Venick, Esq.

Email:
lvenick@loeb.com

 

17.
No party hereto may assign either this letter agreement or any of its rights, interests, or obligations hereunder without the
prior written consent of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual
and shall not operate to transfer or assign any interest or title to the purported assignee. This letter agreement shall be binding
on the parties hereto and any successors and assigns thereof.

 

18.
This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter
hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral,
to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement
may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision,
except by a written instrument executed by all parties hereto.

 

    	8

     

    

 

19.
The undersigned acknowledges and understands that the Underwriters and the Company will rely upon the agreements, representations
and warranties set forth herein in proceeding with the IPO. Nothing contained herein shall be deemed to render the Underwriters
a representative of, or a fiduciary with respect to, the Company, its shareholders or any creditor or vendor of the Company with
respect to the subject matter hereof.

 

[Signature
pages follow]

 

	 	 	HHG
    Capital Fund SP
	 	 	 
	 	By:	 
	 	Name:	[*]
	 	Title:	[*]
	 	 	 
	 	 	 
	 	 	Kin
    (Stephen) Sze
	 	 	 
	 	 	 
	 	 	Ngai
    Wing (Stephen) Chong
	 	 	 
	 	 	 
	 	 	Dr.
    Augustine Chow
	 	 	 
	 	 	 
	 	 	Dr.
    Hiu Man (Elliott) Cheng
	 	 	 
	 	 	 
	 	 	Dr.
    Clive Tsang
	 	 	 
	 	 	 
	 	 	Forever
    Happiness Limited
	 	 	 
	 	By:	 
	 	Name:	[*]
	 	Title:	[*]

 

    	9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]